Law ❯ Litigation ❯ Corporate Law ❯ Securities Litigation

False Statements

MoonLake Investors Face Dec. 15 Deadline in Securities Suits Over Sonelokimab Claims

Law firms are recruiting potential lead plaintiffs following Phase 3 results that contradicted MoonLake’s touted Nanobody advantages.

KBR Investors Face Nov. 18 Deadline to Seek Lead Role in Securities Suit Over HomeSafe Disclosures